Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Anatomic Stage III Breast Cancer AJCC v8 2Anatomic Stage I Breast Cancer AJCC v8 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Renal Insufficiency, Chronic 1Prostatic Neoplasms 1Pleuropulmonary blastoma 1Pain 1Neuroblastoma 1Melanoma 1Leukemia, Hairy Cell 1Ganglioneuroblastoma 1Dupuytren Contracture 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1Carcinoma, Intraductal, Noninfiltrating 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Watchful Waiting 1Vincristine 1Topotecan 1Specimen Handling 1Razoxane 1Observation 1Magnetic Resonance Spectroscopy 1Ifosfamide 1High-Energy Shock Waves 1Doxorubicin 1Dexrazoxane 1Dactinomycin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleuropulmonary blastoma × High-Energy Shock Waves × 90 days × Clear all
NCT06647953 2026-05-05

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Children's Oncology Group

Phase 3 Recruiting
110 enrolled

Pleuropulmonary blastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡